Composition:

  • Unibrol syrup: Each 5ml contains 125mg aminosidine U.S.P (as sulphate).
  • Unibrol tablet: Each tablet contains 250mg aminosidine U.S.P (as sulphate).

Clinical pharmacology:
Aminosidine is active against various protozoa including: Leishmania spp; Entamoeba histolytica, and Cryptosporidium spp. In addition, it has an antibacterial spectrum similar to that of neomycin. It is active against many strains of gram-negative bacteria including species of Brucella, Calymmatobacterium, Campylobacter, Citrobacter, Escherichia, Enterobacter, Klebsiella, proteus, Serratia Vibrio and Yersinia. Aminosidine has been reported to be active against Mycobacterium tuberculosis but lacks activity against Pseudomonas aeruginosa.

Pharmaceutical product